Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Virtus LifeSci Biotech Clinical Trials ETF
BBCARCA
Sector
Healthcare
Region
US
AUM
10.50M
Fund Score
Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC) Quotes, Forecast and News Summary
Virtus LifeSci Biotech Clinical Trials ETF (ARCA: BBC) stock price, news, charts, stock research, profile.
| Open | $24.17 |
| High | $24.17 |
| 52 Wk High | $31.99 |
| AUM | 10.50M |
| Dividend | $0.08 |
| Ex-Div Date | Dec 20, 2023 |
| Volume | 2.62K |
| Market Cap | $2.01B |
| Mgmt Fee | 0.79% |
| P/E Ratio | 66.27 |
| Prev. Close | $24.33 |
| Low | $24.17 |
| 52 Wk Low | $22.24 |
| Shares Out | 400.00K |
| Yield | 0.32% |
| Div. Freq | Annual |
| Avg. Volume Daily | 3.15K |
| Beta | 1.05 |
| Avg. Expense Ratio | 0.79% |
| P/B Ratio | 2.99 |
Recent News
Why Is uniQure Stock Skyrocketing On Tuesday?
Nabaparna Bhattacharya
3 ETFs With Q2 Gains Of At Least 30%
ETF Professor
FAQ
Q
How do I buy Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock?
A
You can purchase shares of Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC) through any online brokerage.
Q
Who are Virtus LifeSci Biotech Clinical Trials ETF (BBC) competitors?
A
There are no as such competitors for Virtus LifeSci Biotech Clinical Trials ETF.
Q
What is the forecast, or price target, for Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock?
A
There is no analysis for Virtus LifeSci Biotech Clinical Trials ETF to provide a consensus price target.
Q
What is the current price for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?
A
The stock price for Virtus LifeSci Biotech Clinical Trials ETF (ARCA: BBC) is $24.23 last updated December 23, 2024 at 11:48 AM EST.
Q
Does Virtus LifeSci Biotech Clinical Trials ETF (BBC) pay a dividend?
A
A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2017 to stockholders of record on December 20, 2017.
Q
When is Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC) reporting earnings?
A
Virtus LifeSci Biotech Clinical Trials ETF does not have any upcoming earnings scheduled.
Q
Is Virtus LifeSci Biotech Clinical Trials ETF (BBC) going to split?
A
There is no upcoming split for Virtus LifeSci Biotech Clinical Trials ETF.
| Open | $24.17 |
| High | $24.17 |
| 52 Wk High | $31.99 |
| AUM | 10.50M |
| Dividend | $0.08 |
| Ex-Div Date | Dec 20, 2023 |
| Volume | 2.62K |
| Market Cap | $2.01B |
| Mgmt Fee | 0.79% |
| P/E Ratio | 66.27 |
| Prev. Close | $24.33 |
| Low | $24.17 |
| 52 Wk Low | $22.24 |
| Shares Out | 400.00K |
| Yield | 0.32% |
| Div. Freq | Annual |
| Avg. Volume Daily | 3.15K |
| Beta | 1.05 |
| Avg. Expense Ratio | 0.79% |
| P/B Ratio | 2.99 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Dec 16, 2014 |
| Managers | Seth Kadushin Matthew B. Brown Andrew McDonald Paul Yook |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved